A Case Report of Saccharomyces cerevisiae Fungemia in a Premature Infant Following Probiotic Treatment
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Probiotics are used to restore and maintain the healthy intestinal microflora. Although Saccharomyces cerevisiae (SC) is considered as a non-pathogenic yeast, administration of SC as a probiotic is associated with a rare cause of fungemia in immunocompromised patients with central venous catheter insertion. We encountered a case of SC fungemia in a premature infant who presented with respiratory distress syndrome and had undergone central venous catheterization.
Abstract
Probiotics are used to restore and maintain the healthy intestinal microflora. Although Saccharomyces cerevisiae (SC) is considered as a non-pathogenic yeast, administration of SC as a probiotic is associated with a rare cause of fungemia in immunocompromised patients with central venous catheter insertion. We encountered a case of SC fungemia in a premature infant who presented with respiratory distress syndrome and had undergone central venous catheterization.
참고문헌 (13)
- Fuller R, "Probiotics in man and animals", J Appl Bacteriol, pp.365~378 (1989)
- Salminen S, "Demonstration of safety of probiotics-a review", Int J Food Microbiol, pp.93~106 (1998)
- Carroll KC, "Manual of Clinical Microbiology", American Society for Microbiology, ~ (2019)
- Hennequin C, "Possible role of catheters in Saccharomyces boulardii fungemia", Eur J Clin Microbiol Infect Dis, pp.16~20 (2000)
- Munoz P, "Saccharomyces cerevisiae fungmia : an emrging infectious disease", Clin Infect Dis, pp.1625~1634 (2005)
- Pérez-Cantero A, "Antifungal susceptibility of Saccharomyces cerevisiae and therapy in a murine model of disseminated infection", Rev Iberoam Micol, 36, pp.37~40 (2019)
- Lee HY, "Two cases of Saccaharomyces cerevisiae fungemia in patients with hematologic malignancies", Infect Chemother, pp.477~480 (2012)
- Roy U, "Seven cases of Saccharomyces fungaemia related to use of probiotics", Mycoses, pp.375~380 (2017)
- Kim CS, "Saccharomyces cerevisiae sepsis after treatment of Saccharomyces boulardii probiotics in premature infants", Korean J Perinatol, pp.52~56 (2011)
- Reid G, "Potential uses of probiotics in clinical practice", Clin Microbiol Rev, pp.658~672 (2003)
- Lee SJ, "Effects of probiotics on enteric flora and feeding tolerance in preterm infants", Neonatology, pp.174~179 (2007)
- Romanio MR, "Saccharomyces cerevisiae fungemia in a pediatric patient after treatment with probiotics", Rev Paul Pediatr, 35, pp.361~364 (2017)
- Atıcı S, "Catheter-related Saccharomyces cerevisiae fungemia following Saccharomyces boulardii probiotic treatment : in a child in intensive care unit and review of the literature", Med Mycol Case Rep, 15, pp.33~35 (2017)